| Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council. | |
| | |
MedLine Citation:
|
PMID: 21564329 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Corticosteroids are the mainstay of topical therapies for the treatment of mild to moderate psoriasis. Selection of vehicle, concentrations of corticosteroid and coadministered medications, and frequency of administration are critical factors that enhance bioavailability of topical corticosteroids. Topical corticosteroids are commonly used as polytherapy and combination therapy with other agents, such as salicylic acid, vitamin D analogues and tazarotene. Combinations are selected for the ability to enhance efficacy while minimizing corticosteroid-related side-effects, such as cutaneous atrophy. New, innovative products such as sprays, foams and nail lacquers provide opportunities to tailor treatment for individuals, which promotes patient adherence to medications. This review covers features of topical corticosteroid formulations that affect bioavailability, efficacy and safety when used as monotherapy and in combination with other agents for the treatment of mild to moderate psoriasis. |
| | |
Authors:
|
Pcm van de Kerkhof; K Kragballe; S Segaert; M Lebwohl; |
Related Documents
:
|
943579 - Prognosis for resolution of moderate, primary reflux in girls. 18718179 - Comparison of the pharmacological effects of panax ginseng and panax quinquefolium. 1745179 - The royal commission into aboriginal deaths in custody. aspects of medical interest. 14194099 - Nicotinic acid analogs: effects on response of chick embryos and hens to organophosphat... 14556359 - Appropriate medical care for persons in detention. 21142259 - Adverse effects and tolerability of medications for the treatment of tobacco use and de... 3928359 - Recent pcb accidents in finland. 3613799 - Penetrating neck injuries during the lebanese war: aubmc experience. american universit... 15010719 - Changes in sexual function secondary to medication effects. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-13 |
Journal Detail:
|
Title: Journal of the European Academy of Dermatology and Venereology : JEADV Volume: - ISSN: 1468-3083 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9216037 Medline TA: J Eur Acad Dermatol Venereol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology. |
Affiliation:
|
Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Department of Dermatology, Århus University Hospital, Århus, Denmark Department of Dermatology, University Hospital Leuven, Leuven, Belgium Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results fr...
Next Document: A two-component system, an anti-sigma factor and two paralogous ECF sigma factors are involved in th...